BioHarvest Sciences Inc. Common Stock (BHST) Earnings History
Annual and quarterly earnings data from 2013 to 2024
Loading earnings history...
BHST EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BHST Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 55.4% | -27.7% | -51.3% |
| 2023 | 44.5% | -78.6% | -99.1% |
| 2022 | 22.2% | -193.0% | -204.4% |
| 2021 | 31.9% | -403.9% | -467.5% |
| 2020 | 34.8% | -1557.1% | -1662.6% |
Download Data
Export BHST earnings history in CSV or JSON format
Free sign-in required to download data
BioHarvest Sciences Inc. Common Stock (BHST) Earnings Overview
As of May 8, 2026, BioHarvest Sciences Inc. Common Stock (BHST) reported trailing twelve-month net income of -$12M, reflecting +14.0% year-over-year growth. The company earned $-0.68 per diluted share over the past four quarters, with a net profit margin of -51.3%.
Looking at the long-term picture, BHST's historical earnings data spans multiple years. The company achieved its highest annual net income of $0 in fiscal 2013.
BioHarvest Sciences Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NXRT (-$32M net income, -12.7% margin), GFAI (-$24M net income, -16.1% margin), SIGA (-$4.04T net income, 24.6% margin), BHST has room to improve margins relative to the peer group. Compare BHST vs NXRT →
BHST Earnings vs Peers
Earnings metrics vs comparable public companies
BHST Historical Earnings Data (2013–2024)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$13M | -2.8% | -$7M | $-0.80 | -51.3% | -27.7% |
| 2023 | -$13M | -11.8% | -$10M | $-0.93 | -99.1% | -78.6% |
| 2022 | -$11M | -14.3% | -$11M | $-0.70 | -204.4% | -193.0% |
| 2021 | -$10M | -49.3% | -$8M | $-0.70 | -467.5% | -403.9% |
| 2020 | -$7M | -24.0% | -$6M | $-0.70 | -1662.6% | -1557.1% |
| 2019 | -$5M | - | -$2M | $-1.75 | -2435.8% | -1059.6% |
| 2018 | $0 | - | -$4M | $-2.34 | - | - |
| 2017 | $0 | - | $0 | $-0.21 | - | - |
| 2016 | $0 | - | $-93,081 | $-0.19 | - | - |
| 2015 | $0 | - | $-127,743 | $-0.44 | - | - |
See BHST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BHST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BHST vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonBHST — Frequently Asked Questions
Quick answers to the most common questions about buying BHST stock.
Is BHST growing earnings?
BHST EPS stands at $-0.68, with +14.0% growth matching the 5-year CAGR of N/A. TTM net income is $-12M. Earnings trajectory remains consistent.
What are BHST's profit margins?
BioHarvest Sciences Inc. Common Stock net margin is -51.3%, with operating margin at -27.7%. Below-average margins reflect competitive or cost pressures.
How consistent are BHST's earnings?
BHST earnings data spans 2013-2024. The current earnings trend is +14.0% YoY. Historical data enables comparison across business cycles.